FN1 and cancer: The demonstration that B-FN is a cancer- and angiogenesis-associated ECM component and that murine monoclonal antibodies against B-FN that are injected i.v. into tumor-bearing mice selectively accumulate on neoplastic tissues, prompted the production of human recombinant antibodies from human scFv libraries [14].